120 related articles for article (PubMed ID: 3779839)
1. Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs.
Strubin M; Long EO; Mach B
Cell; 1986 Nov; 47(4):619-25. PubMed ID: 3779839
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain.
Strubin M; Berte C; Mach B
EMBO J; 1986 Dec; 5(13):3483-8. PubMed ID: 3104027
[TBL] [Abstract][Full Text] [Related]
3. Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation.
O'Sullivan DM; Noonan D; Quaranta V
J Exp Med; 1987 Aug; 166(2):444-60. PubMed ID: 3036998
[TBL] [Abstract][Full Text] [Related]
4. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain.
Arunachalam B; Lamb CA; Cresswell P
Int Immunol; 1994 Mar; 6(3):439-51. PubMed ID: 8186195
[TBL] [Abstract][Full Text] [Related]
5. Localization of HLA-DR alpha-chain messenger ribonucleic acid in normal and autoimmune human thyroid using in situ hybridization.
Piccinini LA; Goldsmith NK; Schachter BS; Davies TF
J Clin Endocrinol Metab; 1988 Jun; 66(6):1307-15. PubMed ID: 2453529
[TBL] [Abstract][Full Text] [Related]
6. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
7. HLA DR, DQ, and DP antigen expression in rheumatoid synovial cells: a biochemical and quantitative study.
Teyton L; Lotteau V; Turmel P; Arenzana-Seisdedos F; Virelizier JL; Pujol JP; Loyau G; Piatier-Tonneau D; Auffray C; Charron DJ
J Immunol; 1987 Mar; 138(6):1730-8. PubMed ID: 3102596
[TBL] [Abstract][Full Text] [Related]
8. Isolation of cDNA clones encoding HLA-DR alpha chains.
Wake CT; Long EO; Strubin M; Gross N; Accolla R; Carrel S; Mach B
Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6979-83. PubMed ID: 6817331
[TBL] [Abstract][Full Text] [Related]
9. Extensive polymorphism surrounding the murine Ia A beta chain gene.
Robinson RR; Germain RN; McKean DJ; Mescher M; Seidman JG
J Immunol; 1983 Oct; 131(4):2025-31. PubMed ID: 6311906
[TBL] [Abstract][Full Text] [Related]
10. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
Lamb CA; Cresswell P
J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
[TBL] [Abstract][Full Text] [Related]
11. Isolation of distinct cDNA clones encoding HLA-DR beta chains by use of an expression assay.
Long EO; Wake CT; Strubin M; Gross N; Accolla RS; Carrel S; Mach B
Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7465-9. PubMed ID: 6818545
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical analysis of a cell transfected with an HLA-DR gene reveals a new alloantigenic specificity within HLA-DRw52.
Tosi R; Tanigaki N; De Préval C; Gorski J; Mach B
Eur J Immunol; 1986 Dec; 16(12):1603-8. PubMed ID: 2434336
[TBL] [Abstract][Full Text] [Related]
13. Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients.
Wilkinson D; de Vries RR; Madrigal JA; Lock CB; Morgenstern JP; Trowsdale J; Altmann DM
J Exp Med; 1988 Apr; 167(4):1442-58. PubMed ID: 3128633
[TBL] [Abstract][Full Text] [Related]
14. Constitutive and induced expression of the individual HLA-DR beta and alpha chain loci in different cell types.
Berdoz J; Gorski J; Termijtelen AM; Dayer JM; Irlé C; Schendel D; Mach B
J Immunol; 1987 Aug; 139(4):1336-41. PubMed ID: 3112231
[TBL] [Abstract][Full Text] [Related]
15. Translation initiation and assembly of peripherin in cultured cells.
Ho CL; Chin SS; Carnevale K; Liem RK
Eur J Cell Biol; 1995 Oct; 68(2):103-12. PubMed ID: 8575457
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of HLA-DR5 detected by serologic, cellular, and molecular techniques.
Singal DP; Butler L; Reid B; D'Souza M; Lamontagne L
Transplant Proc; 1987 Feb; 19(1 Pt 1):822-5. PubMed ID: 3493565
[No Abstract] [Full Text] [Related]
18. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
19. Regulation of HLA-DR and invariant chain expression by human peripheral blood mononuclear cells with lead, interferon-gamma, or interleukin-4.
Guo TL; Mudzinski SP; Lawrence DA
Cell Immunol; 1996 Jul; 171(1):1-9. PubMed ID: 8660831
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR gene expression in a proliferating human thyroid cell clone (12S).
Cone RD; Platzer M; Piccinini LA; Jaramillo M; Davies TF
Endocrinology; 1988 Oct; 123(4):2067-74. PubMed ID: 2843357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
